Earning Position: How Evidence Becomes Authority

IVD Industry Monograph No. 2 — Persodia Research

A diagnostic test proven to work by every standard medicine recognises, for twenty-five years. Most hospitals in Europe still do not use it the way the evidence says they should.

This is not an anomaly. It is the structural condition that governs every diagnostic technology that attempts to convert regulatory clearance into clinical scale. Evidence forms. It accumulates. It circulates across institutions. But it does not remain where it is built, and it does not arrive in practice in the form required for action.

This monograph examines why — and what that condition means for everyone who builds, funds, or depends on diagnostic medicine.

The central problem

A diagnostics product can demonstrate biological validity, analytical performance, and clinical relevance across multiple studies. It can meet regulatory requirements and be available at scale. And still, it may not be used — or not used in the way the evidence supports.

The gap between what evidence warrants and what practice delivers is not a failure of science or execution. It is a structural condition. Evidence does not become authority by accumulation alone. It becomes authority when it is recognised, accepted, and acted upon across the system in which it operates — by actors the manufacturer does not control, on timelines it does not set, under criteria it did not define.

This is Evidence Escape. It governs every diagnostic that has ever attempted to move from regulatory clearance to sustained clinical use.

What this monograph examines

Authority in diagnostics is not granted once. It is formed across multiple domains — analytical, clinical, regulatory, economic, operational — each governed by different actors and evaluated under different conditions. Strength in one domain does not compensate for absence in another.

The monograph examines each domain, the interactions between them, and the consequences of evidence that accumulates without aligning. It covers:

• The structural condition that separates evidence from authority — and why the gap persists despite investment
• The seven evidence domains that govern adoption and the binding constraint principle
• Field observations from ESCMID Global Munich 2026 across six companies and the full clinical scientific programme
• The connected laboratory asset — evidence already being generated that the industry has not recognised as such
• The alignment logic that determines whether evidence becomes position or remains valid but unused

Analytical basis

The monograph draws on the structural framework developed in Inside the Clinical Diagnostics Industry: Constraints Shaping Strategy — Towards Health Intelligence (Oliveira, 2026) and on direct field observation at ESCMID Global Munich 2026. It is the second publication in the IVD Industry Monograph series — the primary analytical output of Persodia Research.

About the series

Each monograph in the IVD Industry Monograph series examines a single structural question at the intersection of industry organisation, clinical deployment, and market economics. The series is observational rather than prescriptive, cumulative rather than episodic. Each publication builds on the framework established in the book and extended by prior monographs.

Monograph No. 1 — Crossing from Analytical to Diagnostics: The Difficulty is the Moat — examined the structural distance between the analytical and diagnostics industries and the conditions required to cross from one to the other.

Assumed knowledge

The monograph assumes familiarity with the diagnostics industry and with the institutional conditions of clinical deployment. Readers without direct commercial or technical experience in the sector will find the structural argument accessible but will benefit from prior reading of Inside the Clinical Diagnostics Industry.

Acess

This monograph is available without charge. Access requires a brief declaration of context and purpose — the authors wish to understand who engages with the material and in what context. Full copyright is retained by the authors. The material may be read, cited, and discussed freely. It may not be reproduced or repurposed without prior written permission.